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The terms ‘quality of life’ (QoL) and ‘health related
quality of life’ (HRQoL) are fraught with preconcep-
tions, misconceptions and, frequently, confusion:
How are these terms best defined? What are the best
ways to measure them? These challenges, which are
present even in the relatively well-studied fields of
adult physical health, are magnified considerably
when considered in the context of child and adoles-
cent mental health. They are, however, concepts that
are being increasingly discussed by child and ado-
lescent mental health clinicians, researchers and
service planners. The purpose of this review is to
analyse and discuss the concept of QoL and HRQoL
(for simplicity we will use the umbrella term QoL in
this paper except when there is a need to draw more
fine-grain distinctions) as they relate to child and
adolescent mental health, and review the various
reasons for measuring QoL in this population. The
paper is divided into three main sections. First,
we introduce the concept of QoL and draw out the
issues raised with regard to the field of childhood
mental health research and practice. Second, we
discuss the range of challenges raised as we move
from concept to measurement. Third, we review and
contrast some of the many different measurement
tools currently available.
The concept of quality of life: generic and
child-specific considerations
Definitions and concepts
Definitions of quality of life. The concept of QoL and
its relationship with health status has received
increased consideration over recent years. Indeed
Spitzer and colleagues suggested that the main goal
of healthcare is to improve patients’ perceptions of
their health and the extent to which health problems
interfere with their QoL (Spitzer et al., 1995). There
are multiple definitions of QoL: At its most simple
it can mean happiness, or economic security and
stability, or even a sense of community and belong-
ing. From an academic perspective, Eiser and Morse
(2001a) describe five relevant levels of definition
(philosophical, economic, sociological, psychological
and medical) of which the psychological and medical
perspectives are most clearly relevant here. The
psychological approach emphasises individual self-
appraisal; a person with a good QoL will have high
self-esteem, be able to make decisions, be active,
happy and feel fulfilled. Even where these goals
remain unmet there is a clear implication that the
closer one is to attaining them the higher is one’s
QoL.
The medical perspective on QoL initially emerged
as a response to advances in healthcare. These made
it possible to keep patients, suffering from previously
fatal conditions, alive while not actually curing their
disease. With such advances, the measurement of
treatment benefits was extended from indices of
mortality to incorporate patients’ feelings and per-
ceptions about the quality of their extended lives.
The QoL concept encourages a contrast between
whether a patient ‘feels’ better (QoL) or ‘is’ better
(‘health status’). This shift has encouraged clinicians
to focus on outcomes which are more difficult for
them to assess directly themselves and, which,
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therefore, often have not received adequate attention
in either clinical or research settings. Objective
measurement of functional impairment is of course
possible in most of these domains; however,
impairment in relation to the norm does not neces-
sarily imply that a patient’s perception of their status
in that domain is suboptimal. As such, ‘health sta-
tus’ (i.e., presence/absence of symptoms), functional
impairment (an objective measurement of impact on
functioning) and QoL (self-perception of well-being)
are three different potential outcomes of disease and
treatment impact research.
Another important aspect of the original QoL
construct is its intrinsically subjective nature and
the associated assumption that it can only be prop-
erly assessed from the patient’s perspective (Matza,
Swensen, Flood, Secnik, & Leidy, 2004b). Whilst we
agree that an individual will have a unique and
privileged insight with regard to their own situation
and that it is important to draw a distinction between
this and other perspectives, it is clear that others,
and in particular where children are concerned,
parents, can make important contributions to our
understanding of the broader impact of a child’s
health status on QoL. Important questions include:
What are the relationships between these different
perspectives? Do these relationships vary depending
on which aspect of QoL is measured, the informant,
the age and gender of the child/adolescent and the
specifics of their mental health condition?
It is also important that we acknowledge the often
complex relationships between what is happening to
you in your life, what you think is happening to you
and how you feel about what you think is happening
to you. In so far as self-report QoL measures are
subjective they will be more likely to capture the
‘think’ and ‘feel’ aspects of a situation. Clearly this
may correspond more or less closely to the rele-
vance/importance attached to a situation by a sig-
nificant other. Whether this is a strength or a
weakness depends on your frame of reference and
the questions you are seeking to answer. Some au-
thors have proposed combining independent obser-
vations and subjective perspectives within a single
measure of QoL (Testa & Simonson, 1996) and ask
‘what can (or can’t) the child do?’ and ‘how does the
child perceive the illness and what attributions are
attached to it?’ (Schipper, Clinch, & Olweny, 1996).
However, reserving the term QoL for the subjective
perception of well-being, and the term ‘functional
impairment’ for the objective measurement of dis-
ease (and treatment) impact, would be one way of
clarifying these broader measures of outcome. For
this to occur, current QoL measures would have to
be refined considerably as most currently include
several questions on functional impairment.
Multidimensional approaches. QoL is generally
accepted as a multidimensional construct which
requires the integration of several domains. Leidy,
Rich, and Geneste (1999) defined QoL as ‘an indi-
vidual’s subjective perception of the impact of health
status, including disease and treatment, on physical,
psychological, and social functioning’. This is com-
patible with the World Health Organisation’s (WHO)
definition of health as ‘a state of complete physical,
mental, and social well-being not merely the absence
of disease or infirmity’ (World Health Organisation,
1947) and the WHOs QoL group’s description of QoL
as ‘the individual’s perception of their position in life,
in the context of culture and value systems in which
they live, and in relation to their goals, expectations,
standards and concerns’ (WHOQOL, 1995). Almost
all QoL definitions and measures include physical,
social and psychological domains (unfortunately
similar domains are often labelled differently).
A cognitive domain is also commonly included (Eiser
& Morse, 2001b). One implication of this multidi-
mensional approach is that QoL cannot be easily
reduced to a single score (Eisen, Ware, Donald, &
Brook, 1979; Ware, Jr., 1984). Whilst there is gen-
eral agreement over the major domains they have
then been subdivided in many different ways. As a
consequence, the resulting measures of QoL each
have a different structure and are thus difficult to
compare directly. For instance, taking three popular
child instruments we see that the Pediatric Quality of
Life Questionnaire (PedsQL; Varni & Burwinkle,
2006) is the simplest of the three, with three core
domains and no sub-domains, the Child Health
Questionnaire (CHQ; Landgraf, Rich, & Rappaport,
2002) has 11 domains and seven sub-domains, and
the Child Health Illness Profile – Child Edition (CHIP-
CE; Riley et al., 2001) has five domains and 12 sub-
domains (Table 1).
Contextual issues. Health-related experiences
occur within contexts and these can affect the way
QoL is perceived. It is, therefore, desirable that QoL is
measuredacrossa rangeofdifferent life-settings.Age-
related differencesmaybe especially important in this
respect. Children, adolescents and adults operate in
different ways across multiple social contexts (e.g.,
family, peer groups, school) and each of these will
contribute to their perceived QoL. Significantly, chil-
dren are often less able than adults to move from one
context to another – an adult facing significant stres-
ses within a work environmentmay choose to leave it,
while this is not so easy for a child who is suffering a
similar situation at school. Furthermore, parental
stress and family disharmonycanbebotha causeand
a consequence of a child’s mental health difficulties.
Broader socio-cultural factors such as ethnicity,
religion and social class clearly influence QoL and
should also be taken into consideration.
Conceptualising quality of life in childhood
Initial attempts to describe the impact of childhood
disease and its treatment focused on functional
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difficulties (e.g., physical abilities, school atten-
dance) and were based on assessments carried out
by the clinician rather than reports by children.
However, pioneering work by Herndon et al. (1986),
and Henning, Tomlinson, Rigden, Haycock, and
Chantler (1988), who respectively assessed both
physical and psychological outcomes for 21 children
who had suffered major burns and 31 survivors of
end-stage renal failure, demonstrated that a child’s
view is important in understanding their adaptation
to major injury (Eiser & Morse, 2001a). QoL has also
been a particular focus in paediatric oncology and
neonatal intensive care. For instance, Lansky and
colleagues developed a simplified set of QoL criteria
for use with children with brain tumours; for use at
the time of hospitalisation, clinic visits, and/or
diagnostic procedures (Lansky, List, Lansky, Cohen,
& Sinks, 1985; Lansky, List, Lansky, Ritter-Sterr, &
Miller, 1987).
Two separate lines of work emerged from these
landmark studies. One sought to develop generic
measures that allowed the comparison of QoL across
different health problems and between those who do
and do not have health problems. One goal was to
allow for the assessment of a broad range of areas
from the patient’s perspective without over burden-
ing individuals with questionnaires. Prior to this
time patients were being presented with increasingly
bulky booklets that brought together a disparate set
of detailed questionnaires, one for each domain of
interest. One of the achievements of Quality of Life
research has been to enable the assessment of a
range of different areas of functioning whilst using a
relatively small number of items. The other line of
work focused on disease-specific measures of QoL
which, among other things, allowed researchers to
measure change following treatment. In these stud-
ies QoL was often seen as synonymous with ‘psy-
chosocial problems’ and so broader aspects of QoL
described above were not measured.
The number of QoL studies has grown enor-
mously. Bullinger and Ravens-Sieberer (1995)
estimated that 13% of the over 20,000 QoL related-
publications involved children, while 320 were spe-
cifically concerned with QoL and childhood disease.
The authors pointed out several limitations and
concluded that many studies should be considered
as little more than descriptions of instruments
rather than studies of QoL and disease. Common
problems were the lack of a developmental approach
(only 19% of studies addressed age differences) and
the failure to assess the children’s views.
Since 1995, with more measures of childhood QoL
appearing, the lack of consensus regarding the pre-
cise definition of QoL is even more pronounced (e.g.,
Eiser et al., 1999; Koot, 2001; Spieth & Harris,
1996). For instance, general measures of cognitive
development, temperament or social abilities are
included in some scales whilst others adopt a nar-
rower view. Using strict inclusion criteria, Eiser and
Morse (2001a) identified 19 generic and 24 disease-
specific childhood QoL measures. Of these, 17
measures were child report only, 7 were adult report
only and 16 had both child and adult versions.
Establishing the psychometric properties of QoL
measures is now seen as a priority, partly because of
their use as important supplementary outcomes in
clinical trials.
QoL and mental health in childhood
There are several reasons to measure QoL in children
with mental health problems.
Quality of life as gold standard. For Eiser and
Morse (2001a) QoL is a ‘gold standard’ against which
other health outcomes should be assessed. This
implies, for instance, that within clinical practice
short-term reductions in symptoms can be out-
weighed by disadvantageous longer-term outcomes
that reduce overall QoL. This insight leads to ques-
tions such as: Does the weight gain often associated
with the use of atypical antipsychotics outweigh the
reduction in aggressive behaviour? Is a reduction in
the core symptoms of attention deficit/hyperactivity
disorder (ADHD) treatment with medication also
associated with an improvement in QoL? The use-
fulness of QoL as a gold standard for accessing
healthcare outcomes is, however, dependent on a
Table 1 Domain and sub-domain structures of the PedsQL,
the CHQ and the CHIP-CE
Domain Sub-domain
PedsQL Physical functioning
Psychological functioning
Social functioning
CHQ Physical functioning
Role/Social functioning Physical
Emotional
Behavioural
General health perceptions
Bodily pain/discomfort
General behaviour
Mental health
Self-esteem
Parental impact Emotional
Time
Family functioning Family activities
Family cohesion
Global item
Change in health
CHIP-CEComfort Physical comfort
Emotional comfort
Restricted activity
Satisfaction Satisfaction with health
Satisfaction with self
Risk Avoidance Individual risk avoidance
Threats to achievement
Resilience Family involvement
Physical activity
Social problem solving
Achievement Academic performance
Peer relations
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wide range of measurement issues many of which
are as yet unresolved (see below).
Helping to establish clinical priorities. QoL mea-
sures can play an important role in clinical decision
making and service planning. Although childhood
mental health problems are now recognised more
frequently, it is not clear whether this reflects a real
increase or greater awareness, better classificatory
and diagnostic systems, increases in parents and/or
clinicians willingness to report symptoms or
decreased tolerance by society of certain behaviours.
To complicate matters further, there are differences
both between and within countries regarding the
most appropriate ways to assess, categorise
and manage childhood mental health problems
(Remschmidt, Belfer, & Goodyer, 2004). However,
despite considerable between-country-variation rec-
ognition levels, it appears that ADHD has a profound
impact on QoL irrespective of national and cultural
boundaries (Preuss et al., 2006), a finding that could
help healthcare planners set priorities This sort of
thinking is reinforced by the demonstration that
mental health problems often impact on QoL more
than common physical disorders (Sawyer et al.,
2000, 2002). Introducing QoL into the equation may
redress the current imbalance of provision between
mental and physical health services.
Health economics. The decisions of health providers
are often hindered by a lack of good quality data on
both the impact on QoL of childhood mental health
problems and the potential benefit of therapeutic
interventions. This is because QoL measures are
central to estimates of the cost-effectiveness of
treatments and so to decisions about reimbursement
of treatment costs. Unfortunately, there are cur-
rently few reliable data within child and adolescent
mental health to enable accurate cost-effectiveness
calculations. King and colleagues (2006) attempted a
cost-effectiveness comparison between different
pharmacological treatments for ADHD. They found
that most data had been calculated on a hypothetical
basis by experts and concluded that ‘It may be useful
when possible to collect data from the children to
obtain a better understanding of treatment from a
patient’s perspective and to estimate patient-based
measures of clinical outcome’ (King et al., 2006;
p. 127). In an attempt to remedy this situation, four
studies have calculated health-state related utility
scores (QUALYs; see below) for children with ADHD
(Coghill et al., 2004; Gilmore & Milne, 2001; Matza et
al., 2005b; Secnik et al., 2005).
Community health status. QoL measures can also
play an important part in measures of the health
status of communities enabling an evaluation of how
well a healthcare system is meeting the health needs
of the population as a whole and of various
important and vulnerable subgroups within it (e.g.,
children in local authority care, victims of abuse and
neglect, those suffering from chronic physical or
mental health problems etc.). The use of QoL data
ensures that the voice of the consumer is heard and
considered alongside other objective evidence.
Service level planning and audit. Within individual
services the routine measurement of QoL can
provide a more comprehensive picture for service
managers of the similarities and differences between
patient groups and, therefore, increase the potential
for more evidence-based resource allocation. This
can potentially facilitate treatment planning to
improve the holistic management of children’s
problems. Before this can be achieved we need, for
example, to develop a better understanding of the
impact that different treatments known to be effec-
tive in reducing symptoms have on QoL and how
different treatments compare.
Planning individual treatment. At an individual
level, QoL can allow clinicians to better integrate the
child’s perspective into their clinical management.
The importance of involving children in their own
healthcare has been stressed by many governments
and organisations (House of Commons Health
Committee, 1997). The potential benefits of such an
approach include not only the targeting of treat-
ments more effectively to areas which really matter to
the child but also the promotion of better concor-
dance between the patient and the clinician and,
therefore, compliance and adherence to treatments.
Whilst QoL and clinical status are linked, they are
not synonymous with each other. Smith et al. (1999)
found that patients placed greater emphasis on
psychological functioning when rating their QoL,
and on physical functioning when rating health
status. Interestingly, neither QoL nor health status
was predicted by social functioning (Smith, Avis, &
Assmann, 1999). Although somewhat limited by the
use of a single summary score to describe the multi-
factorial QoL concept, Rimmer, Campbell, and Cog-
hill (2007) found that whilst the correlation between
child and parent QoL judgements was strong
(r = .67), the correlations between parent and clini-
cian (r = .42) and particularly between child and
clinician (r = .29) were substantially lower. This
suggested that, whilst in one sense parents can act
as reasonable proxies for their children, it seems
likely that parents and their child are rating different
aspects of the child’s life and that both are rating
something different from the clinician. An alternative
approach to integrating QoL into treatment involves
assessing the discrepancy between an ideal and
perceived self, indicating potential targets for inter-
vention.
The development of new treatments. There has
been much interest recently in the use of QoL mea-
sures to index the value of new treatments. QoL
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measures, as noted above, represent a key patient-
reported outcome (PRO) considered by regulatory
authorities in licensing and labelling claims. The
rationale for this comes from the realisation that
some treatment effects are known only to the patient.
The systematic assessment of the patient’s perspec-
tive can provide valuable insights into treatment
costs and benefits that may be obscured when fil-
tered through the clinician’s perspective. The dem-
onstration of a differential impact of different
treatments with respect to QoL, which are otherwise
similar in terms of symptom reduction, could also
assist purchasers to make decisions regarding the
reimbursement of new and more expensive treat-
ments and promote evidence-based choices between
treatments amongst clinicians.
Measuring QoL in relation to child mental
health
The practical value of the QoL concept depends
entirely on whether it can be operationalised appro-
priately and measured with reliability and validity.
Many issues remain unresolved in this regard (see
Committee For Medicinal Products For Human Use,
2005; Eiser & Morse, 2001b; FDA, 2006). Arpinelli
and Bamfi (2006) point out that whilst the ‘opera-
tional application of concepts and their validation
process have been well codified, few attempts have
been made to standardise the evaluation of instru-
ments characteristics’.
General issues
Distinction between physical and mental health
domains. Whilst difficulties in ‘psychological’ func-
tioning are frequently associated with physical dis-
orders, they are the signature component of mental
health problems and psychiatric disorders. However,
there are also subtle differences between psychopa-
thology (e.g., ‘are you feeling happy?’) and QoL (e.g.,
‘are you feeling as happy as you think you should?’).
Whether or not these distinctions are appropriately
realised by QoL measurement tools will depend to
some degree on the precise wording of the questions
and also on the individual’s appraisal of their situ-
ation. Second, in many physical disorders there is
often a much clearer distinction between symptoms
of disorder and impairment than there is in mental
health. It is, for example, possible to have a very
serious disease like cancer without suffering any
obvious impairment. Impairment is, however,
explicitly required in order for a psychiatric diagno-
sis to be made. Sawyer and colleagues (2002) sug-
gest several differences between impairment and
QoL. Impairment is usually rated or measured by the
clinician, QoL by the patient; impairment is integral
to the illness; QoL is a broader multidimensional
assessment of the impact of illness. However, the two
concepts are related and frequently interact with
each other. Impairment can be broken down into
limitation of function (previously known as disabil-
ity) and limitation of participation (previously known
as handicap). Some aspects of impairment can be
measured directly (e.g., academic functioning in
terms of reading or math levels) whereas others will
have to be derived indirectly (e.g., social integration
via peer nominations). Some domains of impairment
are heavily reliant on self or proxy reporting (e.g.,
ability to keep friends or build up close relationships)
and as a consequence the boundaries between these
domains and QoL are particularly blurred.
Item overlap. This can arise because of similarities
between mental health and QoL items (Ormel et al.,
1994). Interestingly, when Sawyer and colleagues
removed items that potentially confounded mental
health problems and QoL, they found that this made
little difference to the relationships identified between
mental illness and QoL (Sawyer et al., 2000).
The process of instrument development. This is a
complex iterative process typically involving several
stages and which often progresses in a non-linear
fashion. The US Food and Drug Administration
(FDA) (FDA, 2006) and the European Agency for the
Evaluation of Medicinal Products (EMEA) (Commit-
tee For Medicinal Products For Human Use, 2005)
have published detailed guidance on the develop-
ment of patient-reported outcome measures
(including QoL). Both emphasise good measurement
science and systematic development, and both are
‘consistent with best practices in health-outcomes
research’ (Revicki, 2007).
The US Food & Drugs Administration (FDA, 2006)
describes several key stages:
(i) The identification of concepts and domains
important to patients, and the hypothesised
relationships among these concepts.
(ii) The creation of an instrument including; the
generation of items; choosing an appropriate
administration method; appropriate recall period
and response scale. The piloting and refining of
the scale.
(iii) The assessment of the measurement properties
of the instrument including reliability and
validity; respondent burden; further revision of
instrument; the development of scoring proce-
dures and training materials; identification of
meaningful differences.
(iv) Further modification of instrument allowing for a
change in concepts measured, populations
studied, research application, instrumentation
or method of administration.
Whilst reliability is relatively easy to measure
using standard psychometric parameters, validity is
harder to establish definitively in the absence of any
agreed QoL gold standard. However, a number of
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quantitative (e.g., factor analysis) and qualitative
(e.g., cognitive debriefing) techniques have been
introduced to address this limitation (Fayers, Hand,
Bjordal, & Groenvold, 1997; Schmidt & Bullinger,
2003). Content validity has been assessed using
panels (including patient panels) to judge whether an
instrument fully examines the domain of interest.
Predictive validity involves assessing whether an
instrument can reliably assign individuals to clinical
groups and can predict subsequent events, out-
comes or treatment response. Schwartz and Rapkin
(Rapkin & Schwartz, 2004; Schwartz & Rapkin,
2004) have highlighted the potential importance of
the individuals’ appraisal processes when assessing
their own QoL. They argue that some of the apparent
psychometric weaknesses in QoL instruments may
be due to a change in how an individual appraises
their situation as they habituate to symptoms, de-
velop coping strategies or reframe their goals and
expectations. They recommend the integration of an
assessment of appraisal into QoL research and
clinical practice. These processes of accommodation
make interpreting change in QoL following treatment
particularly difficult.
Generic versus disease-specific measures. Dis-
ease-specific measures maximise sensitivity as they
focus on areas of particular concern in relation to a
specific disorder. They are especially valuable for
measuring intervention effects. Generic measures
are designed to be more comprehensive, but are less
likely to be sensitive to treatment-related change.
However, such measures will be more appropriate
when comparing different disorders in different pa-
tient groups or in different individuals. For planning
individual treatment, a combined disease-specific
and generic measure may be the most appropriate.
Whether generic or disease-specific, the QoL mea-
sure must add value to symptom counts or syn-
drome diagnosis.
Profile- or preference-based measures? A profile-
based measure will cover multiple QoL domains
(e.g., physical, psychological, cognitive and social).
Preference-based measures, sometimes referred to
as utility-based measures, share some similarities
with profile-based measures. For example, both
measures often examine the same dimensions of
health. However, whilst profile-based measures re-
port a series of scores and characterise respondents
on each independent dimension of the profile, utility
measures use human judgement to combine and
scale health effects over several different dimensions
into a single score (Lenert & Kaplan, 2000). The
scaling of preference based/utility measures is
always made in terms of some absolute reference
point (often, ‘perfect health’ and death), as opposed
to the population reference point used in many
health-status measures. A preference-based mea-
sure is derived from an initial study of health-related
preferences (e.g., state A vs. state B) that allows the
creation of a metric (i.e., health utilities) which al-
lows the QoL of an individual to be estimated. Utili-
ties are numeric measurements that reflect an
individual’s beliefs about the desirableness of a
health condition and their willingness to take risks
to gain health benefits. This approach is favoured by
health economists as health state utilities can in
turn be used to provide an estimate of quality ad-
justed life years, known as QUALYs, which are cen-
tral to many cost utility analyses.
Choice of domains and sub-domains to be mea-
sured. Domains of interest should be identified
through a mixture of patient interviews, literature
reviews and expert opinion. Physical, psychological,
cognitive and social domains need to be measured;
however, there is less agreement how to best define
sub-divisions within these broad domains. Conse-
quently, current measures feature a wide range of
both overlapping and non-overlapping sub-domains.
This makes it difficult to compare directly the results
of different studies. It is important, therefore, that
the hypothesised relationships between individual
questions, sub-domains and broad domains be
explicitly stated and their scoring algorithms to be
set out clearly. A related difficulty concerns the
equivalence (or non-equivalence) of different do-
mains and sub-domains across different instru-
ments. A partial solution is to use a standardised
scoring system based on general population scores
(e.g., by using T scores). Another technique, often
used in cost-effectiveness studies, is to generate
empirically determined patient-preference ratings to
assign a relative weighting for items and domains in
different instruments.
Measurement issues relating specifically to children
These can be broadly separated into those relating to
age and those relating to proxy reports.
Age issues. Given that QoL is seen primarily as a
patient-reported outcome, the question is raised: ‘at
what age can a child report their QoL?’ This is a
complex issue and one on which expert opinion
varies. A number of factors need to be considered.
Children develop at different rates and it is not
possible to say for certain that a particular child of a
certain age will be able to report their QoL reliably.
For example, some children with generalised learn-
ing disability whose developmental age is lower than
their chronological age will have more difficulty
reporting on their QoL than age-matched peers.
Mental health may manifest as a slowing in the rate
of development and lead to delay in mastering nor-
mal maturational tasks and skills. Some psychiatric
disorders may lead to slower development and diffi-
culties in reporting QoL in some domains. For
example, children with autism may have difficulties
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reporting on peer relationships; children with
depression and anxiety may find reporting on their
internal state more difficult due to emotion-based
cognitive distortions.
Language development will impact upon a child’s
ability to report their QoL and determine the type of
instrument most appropriate to use at particular
ages. Rebok and colleagues (2001) found that only
57% of 5-year-olds, but all 8-year-olds, had a good
understanding of the word ‘nervous’. Reading ability
will determine which children will not be able to
complete particular types of questionnaires.
Effects may be domain specific. Between the ages
of 4 and 6 years children can report about more
concrete domains, like pain and medication use,
whereas only older children can describe the emo-
tional impact of their illness (Annett, 2001; Connolly
& Johnson, 1999; Wallander, Schmitt, & Koot,
2001). Bibace and Walsh (1980) described six
developmentally ordered categories of explanation
the emergence of which was consistent with Piaget’s
stages of cognitive development. Four-year-old
children tended to attribute illness to contagion and
7-year-olds to contagion or vaguely internalised
causes, whilst by 11 years of age the children were
much clearer about the physiological causes of ill-
ness (Bibace & Walsh, 1980). Children as young as 4
or 5 years appear able to report on limited and con-
crete aspects of QoL when methods are develop-
mentally appropriate. Children become more able to
provide a more complete description of QoL with age;
many 9- or 10-year-olds were able to give an account
of subjective concepts such as self-esteem (Landgraf
& Abetz, 1996).
Recall also varies as a function of age/develop-
mental level. Whilst 8-year-old children were able to
recall fairly accurately over a 4-week period, younger
children can have difficulties with much shorter
intervals (e.g., 1 week; Rebok et al., 2001). Children
with mental health problems may have increased
difficulties with recall. It is therefore important that
an appropriate recall period is chosen when design-
ing QoL instruments for use with children.
Several of the above issues have been addressed
by the careful design and testing of QoL instruments
for use in children. Some, however, remain incom-
pletely resolved with regard to one type of health
problem at a specific age or developmental level.
Each instrument needs careful assessment and pilot
testing in each new group of children that it is
applied to, in order to determine the lowest age at
which accurate reports of QoL can be made.
Paediatric QoL measures should be as child
friendly as possible. Unfortunately, many scales are
rather long; some ‘child versions’ are as long as adult
versions and may exceed the attentional capacity of
children. Adult questionnaires typically require a
reading age of around 13 years (Titman, Smith, &
Graham, 1997), making them difficult for many
adults let alone children. Unfortunately, even though
reading age can be easily calculated, it is rarely
reported for child scales.
A range of different response formats (i.e., Likert
scales, graphic, facial expression or visual analogue
scales) and presentations styles (i.e., written, picto-
rial, verbal, computerised and the use of props) have
been utilised in different QoL instruments (Crem-
eens, Eiser, & Blades, 2006, 2007). Likert scales are
the most frequently used and developmental differ-
ences have been noted in children’s ability to
understand and respond to them (Rebok et al.,
2001). For younger children instruments need to be
administered as an interview rather than as a
questionnaire (Juniper, Guyatt, Feeny, Griffith, &
Ferrie, 1997). Several authors have compared the
psychometric properties of the same measure across
several different response formats. Such careful
attention to the formatting and presentation of the
measure is likely to assist completion and increase
the reliability of the measure. Rebok and colleagues
(2001) found that pictorial and graphic techniques
assisted younger children with completion of Likert
scales in the CHIP-CE. Whilst smiley, neutral and
sad faces and other pictorial and graphic techniques
are often used to assist younger children with com-
pletion of Likert scales (Christie et al., 1993), a de-
gree of care is required before applying them with
regard to mental health. For example, children with
depression may respond differently to smileys than
healthy children.
Pictures can be used to engage the child’s interest,
increase their understanding, improve the accuracy
of responding and lower the minimum age of
assessment to around 4 years (Eiser & Morse,
2001b; Harter & Pike, 1984). In other fields,
researchers have shown that the use of props and
puppets increases the number of responses made by
4- and 5-year-olds (Lawford, Volavka, & Eiser, 2001;
Mize & Ladd, 1988). Computer administered mea-
sures may potentially increase the child-centredness
of measures (Eiser, Cotter, Oades, Seamark, &
Smith, 1999; Gringras, Santosh, & Baird, 2006).
Cremeens et al. (2007) compared three different
rating scales (circles, faces and a thermometer-
shaped continuous scale) in children aged between 5
and 9 years of age at two time points. The results
were complex. Overall, faces and thermometer scales
showed highest reproducibility over time. There was
an interaction between age and scales, whereby for
reproducibility over time, the thermometer was most
reliable for 5–6-year-olds and faces was most reliable
for 7–9-year-olds.
One potential solution to ensuring that the scales
are age appropriate is to create multiple versions of a
measure for use with different ages, each measuring
the same general constructs but in slightly different,
and age appropriate, ways. This approach ensures
that each measure is appropriate to measure QoL at
a particular developmental level, but it becomes
difficult to pool and/or compare data across different
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age. Whatever scale is used, greater variability of
responding and subsequent measurement error is
likely with younger children. This means that large
samples will be required.
Whilst the application of QoL measures to young
childrenmay well be feasible and reliable, the validity
and stability of the QoL concept in this group remains
somewhat unclear. Many developmental psycholo-
gists would argue that the majority of children below
the age of 8 will have restricted abilities with respect
to introspection, meta-communication, abstract
thinking, reflection and communication about their
feelings and experiences beyond the here and now
(Bibace & Walsh, 1980). In older children, other
potentially important mechanismsmay becomemore
important in prejudicing their responses to questions
about their QoL, including: social desirability,
intimidation or influence of adults, wish to conceal
their feelings. A demonstration of validity in terms of
longer-term temporal stability or prediction of adult
QoL is lacking.
In order to make a comprehensive assessment of
QoL in children and adolescents, additional QoL
domains specific to these age groups are required.
Eiser and Morse (2001a) argue that in addition to the
generally accepted domains, domains relating to
autonomy and body image are of particular impor-
tance in adolescence. Felce and Perry (1995) added
‘material well-being’ and ‘productive well-being’ do-
mains to their description of the QoL concept for
adults, and although Wallander, Schmitt and Koot
(2001) suggested that these domains could also be
helpfully integrated into child measures, this has not
yet happened. A domain of family functioning and/or
impact on family life is, however, present in most
child QoL measures, but may be more relevant to the
assessment of impairment or disease impact than
QoL per se. Unfortunately, despite these helpful
suggestions, the striking lack of agreement over
which domains are important and should be mea-
sured continues to be a problem for the field.
The use of proxy raters. Who is themostappropriate
person to provide information about children’s QoL?
Whilst accepting that a proxy may, at times, be asked
to provide a rating, Matza et al. (2004b) suggest that
wheneverpossible a child’sQoLof life shouldbebased
on self-rating. This is because (i) it is consistent with
the QoL concept, (ii) it allows for the inclusion of
information from multiple domains and settings (i.e.,
school or day-care vs. home) and (iii) ensures that the
child’s perspective andperceptions are acknowledged
in the decision-making process. Others advocate
using the parent/carer as a proxy respondent where
patients are either too young or too unwell to provide
information. If one takes into account a child’s relative
dependence on their parents and the fact that many
decisions about their healthcare will be made either
by, or in conjunction with, their parents, it seems
reasonable to include parental ratings as a supple-
ment to child ratings when making a comprehensive
assessment of a child’s QoL.
No matter which perspective one takes, there are
several important issues to consider. Concordance
between proxy and child ratings appears limited
(Vogels et al., 1998). A review by Upton, Lawford, and
Eiser (2008) found evidence to suggest that whilst the
parents of children from non-clinical samples tend to
report higher child QoL than children themselves, the
reverse is true for clinical samples. Agreement is
higher in some domains (e.g., observable domains
such as physical functioning) than others (e.g., non-
observables ones such as emotional or social func-
tioning) (e.g., Eiser, Havermans, Craft, & Kernahan,
1995; Varni et al., 1998; Varni, Seid, & Rode, 1999;
Vogels et al., 1998). Exceptions include low proxy–
child correlations for physical functioning (Czyzew-
ski, Mariotto, Bartholomew, LeCompte, & Sockrider,
1994; Theunissen et al., 1998) and high correlations
for social interaction items (Langeveld, Koot, & Pass-
chier, 1997). There wasmore variability in agreement
for social and emotional functioning than for physical
functioning. Little is still known about the impact of
age, gender or type of disorder on agreement. There
seems to be a greater degree of concordance between
parents and their children where an illness is chronic
(Eiser & Morse, 2001b). In one study, the presence of
oppositional defiant disorder/conduct disorder
(ODD/CD) in children with ADHD was associated
with larger discrepancies between parent and child
reports (Klassen, Miller, & Fine, 2006). However, in
general it is not yet clear whether these associations
will differ for children with different types of mental
health problems or whether there is an interaction
between age, gender and type of disorder.
Proxy ratings from different adults are not equiva-
lent (Landgraf & Abetz, 1996). In most instances it is
most appropriate for the proxy to be the parent/carer
as they are closest to the child and are involved daily
with the child. While proxy reports appear to be more
accuratewhen theproxy lives in thesamehouseas the
subject (Epstein, Hall, Tognetti, Son, & Conant,
1989), parents’ assessment of the impact of an illness
on a childmay be biased by how they themselves, and
others in the family, are affected. Relative to parents,
clinicians are not in a good position to assess a
patient’s QoL and tend to underestimate it (Sprangers
& Aaronson, 1992). Glaser, Abdul Rashid, U, and
Walker (1997) found that teachers were reasonably
reliable proxies for most domains of QoL, while
children tended to rate their QoL lower than did their
teachers. However, the potential role of teachers,
day-care staff or other family members has not been
studied sufficiently to make recommendations.
Proxy ratings, even where they do not agree with a
child’s views, can provide an important additional
perspective and may be useful in identifying poten-
tial areas of conflict or concern. This may be espe-
cially important where parents and children have
different levels of maturity or have different under-
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standings and perceptions of the meaning and con-
sequences of illness. Children may not want to ‘let
down’ either themselves or their parents by admit-
ting how much an illness is affecting them or they
may be unaware of the restrictions brought about by
their illness. Some authorities have suggested that
the question is not how accurate are parental reports
but rather what additional information can be gained
from asking a parent to rate their child’s QoL
(Annett, 2001; Eiser & Morse, 2001b).
Whilst the use of a proxy as an additional source of
information has the potential to provide the most
complete picture of a child’s QoL, it brings with it
several methodological problems (Matza et al.,
2004b). Should researchers pool the child and proxy
data into a single rating (overall or per domain) or
should they be analysed and reported separately?
How should disagreement be handled? Unfortu-
nately, there is not yet enough information to inform
the clinician how best to interpret such discrepant
information.
Instruments for measuring children’s quality
of life
Given the complexity of the task of operationalising
and measuring QoL in children, it is important that
researchers and clinicians ensure that they under-
stand the measurement and psychometric proper-
ties of scales they use, both in a general sense but
also in terms of the precise context in which it will
be used. If this data is not available from previous
reports then it will need to be collected.
Desirable characteristics
In reflecting the discussion above, the ideal QoL
instrument would have the following characteristics:
• Validly represent the concept of QoL; i.e., encom-
pass all relevant domains and sub-domains in a
well-balanced multidimensional measure (i.e.,
face, content and predictive validity).
• Avoid overlap with disorder symptoms.
• Take into account important developmental as-
pects, both in content and method, thereby
retaining a maximal parallel between different
versions.
• Reliably measure self and proxy perspectives.
• Be able to measure the discrepancy between a
perceived self and an ideal self.
• Be sensitive to differences or change in QoL (e.g.,
responsiveness to treatment change, discrimi-
nant validity etc.).
• Be applicable to a wide scope of mental health
disorders, as well as somatic diseases and heal-
thy children.
In addition to these characteristics, a disease-
specific QoL measure should be able to give a de-
tailed assessment of the burden of the disorder and
the effects of its treatment.
Unfortunately, few if any instruments for child
QoL have been assessed against all of these criteria
(Upton et al., 2008).
Generic measures
At least seven reviews of generic QoL measures for
children/adolescents have been published over the
past few years (Cremeens et al., 2006; Eiser & Morse,
2001a, 2001b; Grange, Bekker, Noyes, & Langley,
2007; Raat, Mohangoo, & Grootenhuis, 2006;
Schmidt, Garratt, & Fitzpatrick, 2002; Upton et al.,
2008). A comprehensive review of these instruments
is beyond the scope of this review. We focus on three
instruments used in the context of child and ado-
lescent mental health that have been intensively
studied from a psychometric perspective and exist in
multiple languages (Tables 1 and 2). Other measures
are detailed in Table S3 (supplementary material).
Child Health Questionnaire (CHQ; Landgraf,
Abetz, & Ware, 1999). The CHQ:
• Is a widely used QoL measure developed using
traditional qualitative techniques.
• It is available in different languages.
• It has been used in a range of clinical conditions.
• It has 12 subscales and 2 summary scores.
• It has several versions: a lengthy child form (CHQ-
CF-87 items) and different versions of the parent
form (CHQ-PF -28, 50 and 98 items). Unfortu-
nately, these are not parallel versions. There are
many differences between versions to the extent
that scales with similar names contain very dif-
ferent items and are, therefore, difficult to com-
pare with each other.
• Raw scores can be transformed to a 0–100 score,
allowing a comparison of the functioning of chil-
dren across the different domains.
• It has test–retest reliability estimated to be around
.80 (Landgraf et al., 1999; Waters, Salmon, &
Wake, 2000). In a clinical sample, the parent
summary score is reliable, but not all subscale
scores (Raat, Botterweck, Landgraf, Hoogeveen, &
Essink-Bot, 2005). Good reliability has also been
found for the child format (a ‡ .80) in 6 out of the
10 multi-item scales (Landgraf & Abetz, 1997).
• It has moderate inter-informant agreement (Klas-
sen, 2005).
• It shows convergent validity reflected in correlations
between subscales (especially family subscales,
behaviour and the psychosocial summary score)
and symptoms of disorder (Klassen, Miller, & Fine,
2004; Rentz, Matza, Secnik, Swensen, & Revicki,
2005).
• It discriminates between children with mental
disorders and normal controls in terms of psy-
chosocial interference with family life subscale
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scores (Landgraf & Abetz, 1996). In particular, the
parent version of psychosocial sub-scales and the
psychosocial summary scale discriminated be-
tween children with ADHD and normal controls
(Brown et al., 2006; Klassen, Miller, & Fine, 2004;
Landgraf et al., 1999; Matza et al., 2004a; Matza,
Secnik, Mannix, & Sallee, 2005a; Perwien et al.,
2004; Perwien et al., 2006; Rentz et al., 2005;
Sawyer et al., 2002). In contrast, although the
child version discriminates between children with
a severe physical illness (e.g., end stage renal
disease) and normal controls, no differences were
found for children with ADHD (Klassen, 2005;
Klassen, Miller, & Fine, 2006; Landgraf & Abetz,
1997). Therefore, an association between ADHD
symptoms and CHQ QoL was found for the parent
but not child form, suggesting possible single re-
porter-bias. However, similar correlations were
found between eight CHF-PF50 subscales and a
clinician-based rating of ADHD symptom severity
(CGI-ADHD-S; Matza et al., 2004). The parent
emotional and behavioural subscales discrimi-
nated between children with ADHD and children
with depressive disorder (Sawyer et al., 2002).
Children with ADHD scored lower on family
activities and parent time impact scales. The
psychosocial summary scale differentiated
between children with ADHD and those with other
psychiatric diagnoses (Klassen, Miller, & Fine,
2004).
• It is sensitive to ADHD treatment effects in some,
but not all studies (Matza et al., 2004; Perwien et
al., 2004; Rentz et al., 2005; Brown et al., 2006).
• It has minimally important treatment differences
defined (Rentz et al., 2005).
Pediatric Quality of Life Inventory (PedsQL; Varni,
Seid, & Kurtin 2001). The PedsQL:
• Has 23 items and four subscales and also gives
one total score;
• Was developed through focus groups, cognitive
interviews, pre- and field-testing;
• Takes about five minutes to complete (Varni et al.,
1999);
• Has parallel versions for parent/proxy and child
self-report with essentially the same items, but
wording adapted to different age-groups;
• Can be transformed into a 0–100 scale, with higher
scores indicating better QoL;
• Has correlated parent and child forms (between
.50 and .75; Bastiaansen et al., 2004; Varni,
Limbers, & Burwinkle, 2007b);
• Has high consistency for the child and parent
proxy-form (Varni et al., 2007b);
• Differentiates children with chronic illness from
health children on both parent and child reports;
• Can be completed reliably by children as young as
5 years old (Varni, Limbers, & Burwinkle, 2007a);
• Has differentiated children with ADHD and heal-
thy controls in terms of total score for some (Varni
& Burwinkle, 2006) but not other studies (Pon-
gwilairat, Louthrenoo, Charnsil, & Witoonchart,
2005). Where effects for total score are absent,
effects have found for several subscales between
ADHD/disruptive behaviour and other psychiat-
ric diagnoses (Bastiaansen et al., 2004). Children
with anxiety disorders demonstrated lower scores
than children with ADHD/disruptive behaviour
on the emotional subscale. Effect sizes of differ-
ences between the ADHD subgroup and healthy
children were the largest on the school function-
ing subscale both in the parent (ES = 1.35) and
child (ES = 1.13) form (Varni & Burwinkle, 2006).
These results may be explained by the fact that
the PedsQL has items on the emotional subscale
that overlap with symptoms of depression and
anxiety, and there is an apparent overlap between
the items of the school functioning scale and
symptoms of ADHD;
• Has not been used in treatment studies to date.
Child Health and Illness Profile (CHIP; Riley et al.,
2004a, 2004b). The CHIP:
• Has three versions: an adolescent form (CHIP-AE),
an illustrated form for children (CHIP-CE) and
a parallel version to measure the parental
perspective on children’s health and well-being
(CHIP-PRF);
• Produces standardised scores (mean 50 – standard
deviation of 10) allowing comparison between the
different domains;
• Has a pictorial version where a cartoon illustrates
the question, and different sizes of response
circles differentiate the response format;
• Has demonstrated criterion validity against exist-
ing measures. The highest correlations were for
the emotional discomfort items (r = .63) and the
lowest for the peer relationship items (r = .44)
(Riley et al., 2004a);
• Has two items that overlap with ADHD-symptoms
and five with depression or anxiety problems;
• Has adequate internal consistency and convergent
reliability in the parent report form when applied
to 12–18-year-olds (Riley et al., 2004b);
• Has a replicable factor structure (Riley et al.,
2006);
• Has some subscales (i.e., risk-avoidance) that
correlate with ADHD symptoms. (Riley et al.,
2006) and measures of general behaviour prob-
lems (e.g., Strengths and Difficulties Question-
naire);
• Has been used in treatment studies showing sen-
sitivity to change in patients with ADHD following
atomoxetine treatment in an open label study
(Prasad et al., 2007).
Practitioner Review: Quality of life in child mental health 555
 2009 The Authors
Journal compilation  2009 Association for Child and Adolescent Mental Health.
In summary, all three QoL measures provide some
data in relation to children with mental health
problems, but are largely restricted to those with
ADHD. Content validity is most convincingly dem-
onstrated for the CHIP-CE, making it scientifically
the most attractive measure. Parent versions of all
three measures have been shown to discriminate
clinical ADHD samples from controls or norm pop-
ulations, but self-report versions have not. Correla-
tions between symptoms and QoL-subscales are
more pronounced for the CHQ-PF50 than for the
CHIP-CE. A direct comparison of these measures
within the same population so far is unavailable.
Disease-specific measures
In somatic medicine, more than 30 disease specific
instruments or additional modules to generic ques-
tionnaires exist, whereas in mental health care,
these are, so far, restricted to ADHD. Both contain a
mixture of QoL and impairment questions, but
clearly avoid the overlap with symptoms.
The Weiss Functional Impairment Rating Scale is a
50-item parent-rated measure of functioning across
six domains: family, learning and school, life skills,
child’s self-concept, social activities and risky activ-
ities. Each item is measured on a four-point Likert
scale. Ongoing research suggests that the scale has
strong internal consistency, a well-established do-
main structure and is sensitive to change (Weiss &
Brooks, 2007). Correlations with the CHIP-CE do-
mains ranged from –.32 to –.72 (Weiss, personal
communication).
The ADHD Impact Module (AIM) developed by
Landgraf et al. (2002) has still to be widely utilised. It
has identified statistically significant differences be-
tween ADHD-combined and ADHD-inattentive sub-
types, with better functioning at home for the latter.
Disease-specific instruments may be promising
but are still largely in an experimental phase.
Discussion
The QoL field is relatively young and continues to
evolve. The definition and operationalisation of QoL
has, as yet, reached no generally accepted con-
sensus, hence the variety of instruments in the
field. Initial definitions have battled with the issue
of whether the concept is best defined for the
general population or for specific disease entities.
Instruments developed from a conceptual point of
view appear to have a stronger theoretical and
psychometric strength. However, health care
assessment requires that such instruments are
both reliable and valid and that they can reliably
measure changes in QoL following treatment from
the perspective of the child, parents and caregiver.
Whilst this has proved a challenge, it is possible
that this is not entirely due to failings in the
measurement tools. New approaches to the psy-
chometric evaluation that assess appraisal along-
side standard QoL domains could help move the
field forward (Rapkin & Schwartz, 2004; Schwartz
& Rapkin, 2004).
There are outstanding issues concerning the rela-
tionships between QoL, symptoms and impairments.
Many studies have identified significant correlations
between QoL, impairment and symptomatology.
Whilst a correlation between two items does not
indicate that both are necessarily measuring the
same factor (a third intervening or moderating factor
could be responsible for this association), it is clearly
possible that overlap between these factors may lead
to some redundancy. In order to determine the
functional meaning of the association, future QoL
research needs to employ experimental designs
whereby levels of an independent variable are
manipulated to assess effect on levels of QoL inde-
pendently of symptoms.
Issues specific to children include an urgent need
for a better understanding of the development of QoL
from childhood to adulthood. There are no longitu-
dinal studies of development and it is not possible to
discuss the progression or stability of QoL across
development. Age-related differences in language
ability, understanding of the concept of ‘illness’ and
reading ability are each likely to influence the
appraisal and reporting of QoL.
Questions remain even about the most intensively
studied QoL instruments. For example, it is not en-
tirely clear whether instruments such as the CHQ,
PedsQL and CHIP take fully into account the devel-
opmental level and cognitive abilities of the child.
Proxy informants, while providing useful informa-
tion, cannot be considered a replacement for the
child, hence, when making interpretations of data
from studies using proxy information one needs to
bear in mind that this proxy information is primarily
providing the proxy’s perspective, which may be very
different from that of the individual being described.
The value of the concept of QoL to child and
adolescent mental health
QoL has the potential to be an extremely important
concept for the field of child and adolescent mental
health, which can add value to scientific study and
promote improved clinical practice. From a scientific
point of view, including measures of QoL in studies
could result in a better, more broadly contextualised,
understanding of both the causes and consequences
of mental health conditions and include the patient’s
perspective. The inclusion of the QoL concept in
intervention research can facilitate a shift toward a
more general and generalisable improvement and/or
impact on psycho-social well-being. This has the
potential to help ground evidence of symptom
remission within the broader context of the costs and
benefits of a treatment, which in turn can facilitate
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the sort of comprehensive account required for
health economic analyses. More importantly, it can
result in a better understanding of the impact of a
treatment and the significance of treatment effects
from the child’s point of view: a perspective almost
completely overlooked in current clinical trials.
The QoL concept may also be applied usefully
in clinical practice at several levels. Child self-
completed QoL scales could help identify which
outcomes are most important as treatment targets
and provide a more ecologically valid measure of
the positive and negative impact of a treatment
regime. Using parent ratings can provide a sense of
the wider impact of the treatment on the family.
Sawyer et al. (2002) demonstrated that there were
greater similarities than difference in QoL between
groups of children with different psychiatric disor-
ders (e.g., major depressive disorder, ADHD and
conduct disorder) and between these children and
those with chronic physical illnesses. Both they
and Stein and Jessop (Stein & Jessop, 1989) argue
that there will be situations where it would be
better to classify patients by their QoL profiles ra-
ther than their diagnostic groupings. For example:
it may be worthwhile to develop treatments
addressing QoL domains, rather than symptom
domains. QoL measures are also particularly use-
ful in assessing the impact implementing new
treatments or treatment protocols. The publication
and dissemination of such information would be of
great value to service planners. Whilst there are
several examples from paediatric practice where
this has occurred (Bichey et al., 2002; Larsson &
Carlsson, 1996) similar data from mental health is
sparse at the present time.
There is, however, an important caveat to all this:
these ideals remain to a large degree aspirational
until there is a systematic and comprehensive data
on the psychometric properties of QoL instruments
in children and adolescents and of the various
interrelationships between development, age, gender
and disorder in QoL (and its measurement).
Especially the validity of the QoL concept in early
childhood still needs thorough consideration. The
QoL concept and measures clearly still need purifi-
cation to ensure that QoL is disentangled from both
functional impairment and symptoms. Also, an
improvement in short-term self-perceived well-being
may not be predictive at all for long-term (adult)
clinical outcome.
Taking on board issues relating to QoL will have
considerable implications for developers, regulators,
purchasers and providers of healthcare. If QoL is
taken seriously by the healthcare systems, this will
require health regulatory bodies to reconsider what
information is required for determining the effec-
tiveness of an intervention. Similarly, any develop-
ment of a new therapy or modification of an existing
one will need to take account of the distinction noted
between effect and effectiveness. This suggests that
serious implementation of QoL has considerable
consequences not only for the patient and their
family but the entire complex around healthcare,
planning, evaluation and regulation.
Supporting information
Additional supporting information may be found in
the online version of this article:
Table S3. Measures of QoL in children and ado-
lescence (Word document)
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Areas for future research
• To establish the developmental trajectory, longitudinal stability and predictive value of QoL in healthy
children and adolescents and children and adolescents with ill health.
• Does QoL measurement contribute added value over and above symptom-based measures?
• Do disease-specific QoL measures add value over and above generic measures?
• To determine the relationships between the QoL concept and measures of functional impairment on the
one hand and more abstract concepts such as self esteem and happiness, on the other.
• To validate child-self report and parent proxy- report measures and their appropriate roles within the
assessment of child mental health outcomes including how, if at all, should information from these two
perspectives be combined.
• To describe the dynamic nature of QoL in relation to child mental ill health as patients adapt to and cope
with illness.
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Key points
• Quality of life is an intrinsically multidimensional subjective concept defined by the World Health Orga-
nisation as ‘the individuals perception of their position in life, in the context of culture and value systems in
which they live, and in relation to their goals, expectations, standards and concerns’ (WHOQOL, 1995).
• The QoL concept could also be applied usefully in clinical practice at a several levels relating to the
planning and delivery of care to individuals and populations.
• The use of child self-completed QoL scales could help identify which outcomes are most important as
treatment targets and provide a more ecologically valid measure of the positive and negative impact of a
treatment regime.
• Using parent ratings can also give a sense of the wider impact of the treatment on the family.
• There is, however, relatively little data on quality of life in children with mental health problems.
• There are a wide range of ‘measurement issues’ to consider when rating quality of life in children. For this
reason it is necessary to carefully assess the applicability of any QoL measure when using it in a new
group of children (e.g., new age group, cultural setting or disorder).
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